RPL26

Across TCGA pan-cancer cohorts, RPL26 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated RPL26 data layer compared with 24 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher RPL26 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated RPL26 expression acts as an unfavorable survival marker, although some lineages such as COAD and LUAD show a favorable association.

COAD, LUAD, and CCRCC are the cancer types where RPL26 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	IV	1.000	0.605	.043	12	view →
LUAD	DFS	Median	II,III,IV	0.824	0.365	.005	11	view →
CCRCC	OS	Quartile	All	0.396	0.929	.011	10	view →
LSCC	OS	Median	II,III,IV	0.908	0.663	.008	9	view →
HNSC	OS	Tertile	All	1.000	0.342	.038	4	view →
PDAC	OS	Tertile	IV	0.178	0.905	.038	3	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RPL26–COAD (DFS)

Open the COAD breakdown →